Empire Genomics Biocare Medical Acquires Empire Genomics The company believes its existing technology portfolio will be complemented by Empire's molecular probe business, better aiding cancer research and diagnostics. Empire Genomics, Kromatid to Develop Tools for Detecting Cancer Genomic Structural Variations The companies will combine Empire's NGS services and FISH probe portfolio with Kromatid's Pinpoint probes and directional genomic hybridization technology. Empire Genomics Names HemaTone as China Distributor for Cancer Dx Products Empire said it expects to generate $5 million or more in revenues from the Chinese market over the five-year term of the agreement with HemaTone. Empire Genomics Nabs $1.8M Investment The Buffalo, NY-based firm will use the proceeds to grow its marketing, automation, and operations, and to launch additional molecular diagnostic products. New York State Grants Clinical Lab Permit to Empire Genomics The permit will allow the company to offer DNA sequencing and molecular diagnostics for testing of cancer patients. Dec 17, 2015 Empire Genomics Lands CE Mark for Several Products Jan 5, 2015 Empire Genomics Acquires ID Labs Aug 20, 2014 Empire Genomics Partners with Quadpharma to Manufacture ASRs Jul 2, 2014 Empire Genomics Lands $1M Financing Nov 12, 2013 Empire Genomics Clinical Lab Gets CLIA Certification, New York Approval Jun 19, 2013 Life Tech Adds to Clinical NGS Partnerships With University of Buffalo, Empire Genomics Deal Premium Jun 5, 2013 New Next-gen Sequencing Facilities in New York May 29, 2013 With Grant Funding, Empire Advancing Potential Companion Test for Proteasome Inhibitors Premium May 28, 2013 NCI Awards Empire Genomics SBIR Grant to Develop Companion Dx for Multiple Myeloma May 22, 2013 With Exclusive License to Marker, Empire to Launch Neuroendocrine Prostate Cancer Dx This Year Premium May 22, 2013 Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx Nov 29, 2012 Empire Genomics Licenses Biomarker from Emory University for Multiple Myeloma CDx Nov 6, 2012 People in the News: Theresa Brown Premium Nov 2, 2012 In Brief This Week: Becton Dickinson, Corning; Empire Genomics; Emergent Technologies; Octa Phillip Bioscience Managers Jul 27, 2012 People in the News: Michael Becich Premium Apr 24, 2012 Empire Genomics Names Funakoshi its Japan Distributor Nov 9, 2011 Empire Genomics, Icon Team on Personalized Medicine Services Mar 24, 2009 High-Res Arrays Improve Cytogenetics Services as Field Shoots for 'Perfect Platform' Premium Breaking News Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen Consanguinity Contributes to Common Disease Risk, Study Suggests Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.